BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8137538)

  • 1. Inhibition of histone/anti-histone reactivity by histone-binding serum components; differential effect on anti-H1 versus anti-H2B antibodies.
    Bustos A; Boimorto R; Subiza JL; Pereira LF; Marco M; Figueredo MA; de la Concha EG
    Clin Exp Immunol; 1994 Mar; 95(3):408-14. PubMed ID: 8137538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
    Touloupi E; Routsias JG; Tzioufas AG
    Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that a putative anti-idiotypic monoclonal antibody may actually be recognizing circulating immune complexes.
    Subiza JL; Caturla A; Pereira LF; Camargo MC; Bustos A; Boimorto R; de la Concha EG
    J Autoimmun; 1992 Jun; 5(3):363-77. PubMed ID: 1388640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-histone antibodies in SLE and other autoimmune diseases.
    Shoenfeld Y; Segol O
    Clin Exp Rheumatol; 1989; 7(3):265-71. PubMed ID: 2758706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.
    Hardin JA; Thomas JO
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7410-4. PubMed ID: 6584863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to histone, DNA and nucleosome antigens in canine systemic lupus erythematosus.
    Monestier M; Novick KE; Karam ET; Chabanne L; Monier JC; Rigal D
    Clin Exp Immunol; 1995 Jan; 99(1):37-41. PubMed ID: 7529150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients.
    Hylkema MN; van Bruggen MC; ten Hove T; de Jong J; Swaak AJ; Berden JH; Smeenk RJ
    J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus.
    Sun XY; Shi J; Han L; Su Y; Li ZG
    J Clin Lab Anal; 2008; 22(4):271-7. PubMed ID: 18634076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.
    Treves S; Bajocchi G; Zorzato F; Govoni M; Trotta F
    Lupus; 1998; 7(7):479-87. PubMed ID: 9796851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.
    Schett G; Smole J; Zimmermann C; Hiesberger H; Hoefler E; Fournel S; Muller S; Rubin RL; Steiner G
    Lupus; 2002; 11(11):704-15. PubMed ID: 12475000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features.
    Cohen MG; Pollard KM; Webb J
    Ann Rheum Dis; 1992 Jan; 51(1):61-6. PubMed ID: 1540040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on anti-histone fraction antibodies in patients with rheumatic diseases].
    Jiang M; He K; Yan CL
    Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):287-9, 317-8. PubMed ID: 1478127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: glycated-histones as likely trigger for SLE?
    Alam S; Arif Z; Alam K
    Autoimmunity; 2015 Feb; 48(1):19-28. PubMed ID: 25065453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
    Boumba VA; Seferiadis K
    J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.
    Kubo M; Ihn H; Yazawa N; Sato S; Kikuchi K; Tamaki K
    J Invest Dermatol; 1999 May; 112(5):711-5. PubMed ID: 10233761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus.
    Stummvoll GH; Fritsch RD; Meyer B; Hoefler E; Aringer M; Smolen JS; Steiner G
    Ann Rheum Dis; 2009 Jan; 68(1):110-6. PubMed ID: 18375534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.